|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> XL888>> Market Analysis Reports |
Market Analysis Reports of XL888 |
|
Exelixis, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... option to co-develop and co-commercialize XL413. XL888: XL888 is a synthetic inhibitor of HSP90, a chaperone protein ... Exelixis Inc (EXEL) - Financial and Strategic SWOT Analysis Review ... treatment of advanced solid malignancies and XL888, an ATP-competitive inhibitor of HSP90, and ... |